Management of Childhood Pancytopenia
NCT03521947 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2018-05-11
Summary
Pancytopenia is an important hematologic Problem.it is a decrease in all three cellular elements of peripheral blood leading to aneamia, leucopenia and thrombocytopenia.
Conditions
- Pancytopenia
Interventions
- DIAGNOSTIC_TEST
-
Complete blood picture
Iaboratory investigation
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 4 Weeks
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2019-06-01
- Completion
- 2019-12-01
More Related Trials
-
Immune Thrombocytopenia Management in Adults
NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Study of Patients With Thrombocytopenia Following HSCT
NCT02487563 ·Status: COMPLETED ·Phase: PHASE3
-
Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
NCT07182760 ·Status: NOT_YET_RECRUITING
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
NCT05522465 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)
NCT03866798 ·Status: TERMINATED ·Phase: PHASE4
-
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
NCT06281327 ·Status: RECRUITING ·Phase: PHASE2
-
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105 ·Status: NOT_YET_RECRUITING
-
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
NCT03701217 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Immune Markers in Pediatric ITP on Second Line Therapy
NCT06093529 ·Status: NOT_YET_RECRUITING
-
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP
NCT04917679 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
NCT02298075 ·Status: COMPLETED
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00037791 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
Eltrombopag in Chronic ITP
NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4
-
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06168851 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
NCT03771378 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?
NCT04128358 ·Status: UNKNOWN ·Phase: NA
-
Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level
NCT03864796 ·Status: COMPLETED
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura
NCT05093257 ·Status: UNKNOWN
-
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
NCT03939637 ·Status: COMPLETED ·Phase: PHASE3